Surgery Partners (NASDAQ:SGRY) Issues Earnings Results, Misses Estimates By $0.04 EPS

Surgery Partners (NASDAQ:SGRY - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04), Briefing.com reports. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $776.00 million for the quarter, compared to analysts' expectations of $777.77 million. During the same quarter last year, the firm earned $0.10 earnings per share. The business's quarterly revenue was up 8.2% compared to the same quarter last year. Surgery Partners updated its FY 2025 guidance to EPS.

Surgery Partners Stock Performance

Shares of NASDAQ:SGRY traded up $0.30 during trading hours on Friday, hitting $23.94. The stock had a trading volume of 962,649 shares, compared to its average volume of 1,091,189. The stock's fifty day simple moving average is $22.55 and its 200 day simple moving average is $23.23. Surgery Partners has a 1-year low of $19.50 and a 1-year high of $33.97. The firm has a market capitalization of $3.07 billion, a price-to-earnings ratio of -49.88, a PEG ratio of 19.21 and a beta of 1.96. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80.

Analyst Upgrades and Downgrades

SGRY has been the topic of several research analyst reports. Macquarie decreased their target price on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. Royal Bank of Canada reissued an "outperform" rating and issued a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. Finally, Benchmark restated a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a research note on Monday, April 21st. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $34.75.

Insider Buying and Selling at Surgery Partners

In other news, CFO David T. Doherty sold 6,733 shares of the stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the completion of the transaction, the chief financial officer now directly owns 150,868 shares in the company, valued at $3,623,849.36. This trade represents a 4.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Marissa Brittenham sold 3,156 shares of the stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the transaction, the insider now owns 63,408 shares of the company's stock, valued at $1,527,498.72. This trade represents a 4.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Millennium Management LLC boosted its holdings in Surgery Partners by 1,253.7% during the first quarter. Millennium Management LLC now owns 202,274 shares of the company's stock worth $4,804,000 after buying an additional 219,806 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Surgery Partners by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 45,693 shares of the company's stock worth $1,085,000 after buying an additional 2,015 shares in the last quarter. Finally, Empowered Funds LLC boosted its holdings in Surgery Partners by 11.0% during the first quarter. Empowered Funds LLC now owns 12,853 shares of the company's stock worth $305,000 after buying an additional 1,278 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.